US Stock MarketDetailed Quotes
PULM Pulmatrix
- 2.095
- -0.005-0.24%
Trading Jul 29 10:09 ET
7.65MMarket Cap-865P/E (TTM)
2.130High2.095Low6.06KVolume2.120Open2.100Pre Close12.79KTurnover0.17%Turnover RatioLossP/E (Static)3.65MShares2.73052wk High0.40P/B7.65MFloat Cap1.55052wk Low--Dividend TTM3.65MShs Float4235.000Historical High--Div YieldTTM1.67%Amplitude1.550Historical Low2.110Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
Pulmatrix Stock Forum
Pulmatrix Announces Cross License Agreement and Transfer of Laboratory to MannKind Corporation
NEWS
Pulmatrix Announces Peer-Reviewed Publication of Clinical Results for its Orally Inhaled DHE for Acute Migraine (PUR3100)
Pulmatrix announced the publication of clinical results for its orally inhaled DHE (PUR3100) for acute migraine in the peer-reviewed journal Headache: The Journal of Head and Face Pain. The Phase 1 study showed that PUR3100 has rapid systemic pharmacokinetics (PK) similar to intravenous (IV) DHE, with a mean time to maximum concentration (Tmax) of ...
and i also mentioned $Pulmatrix(PULM.US)$ and pulmatrix is still a sleeper waiting to run
livks his lips yum
No comment yet